3 ms·
The problem mostly comes down to patents and licensing... I think eliminating extension patents, and requiring dual sourcing for all medications for FDA approva
by tracker1 7y ago
The problem mostly comes down to patents and licensing... I think eliminating extension patents, and requiring dual sourcing for all medications for FDA approval would resolve a lot of that side. Forcing open-books for medical practices and making it illegal to charge more than 20% difference for the same procedure between two payees within 2 calendar years would help a lot as well. Last would be requiring insurance companies to negotiate as a fiduciary to the benefit holders would wrap it up.
All these things really need to happen to close a lot of the loopholes in the US system.